Plain-English translation of NCT06455098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called the BWI OMNYPULSE pulsed field ablation system to treat paroxysmal atrial fibrillation—a condition where your heart occasionally beats irregularly, often causing symptoms like chest discomfort or shortness of breath. The procedure uses a special catheter (a thin tube) to deliver pulses of energy to specific areas of your heart to help restore normal heartbeat. Researchers want to confirm that this treatment is safe and effective over 12 months.
Current medications for irregular heartbeat don't work for everyone, and some patients need a more definitive treatment option. This trial tests whether this newer pulsed field energy technique can successfully stop these irregular episodes while being safer and easier than some existing procedures.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo one pulsed field ablation procedure where doctors insert a thin catheter through your blood vessels to deliver energy pulses to your heart to restore normal rhythm. You will then be monitored in the hospital briefly before going home. Over the following 12 months, you will return for follow-up visits and tests (such as heart rhythm checks) to monitor your progress and ensure the treatment is working safely and effectively.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States